Skip to content
Drix10 Blog

10-protein panel distinguishes ALS with 98% accuracy

, 8 items in AI in Healthcare and Science, 4 min read

In this digest (8 items)

10-protein blood panel distinguishes ALS patients from healthy people with nearly 98% balanced accuracy. It outperforms a leading biomarker, but testing against similar conditions is still needed.

Key points

  • 10-protein blood panel achieved nearly 98% balanced accuracy distinguishing ALS patients from healthy people

  • Outperformed a leading biomarker; further testing against similar conditions required

Sources

OpenMed 3.1 split_overlap prevents scoring held-out pairs

OpenMed 3.1 cannot score a split where 3 of the 12 held-out pairs in a clinical NLI evaluation also appear in the dev set. The split is labeled split_overlap, the model is never loaded, and any change to the weights after sign-off causes the run to be refused.

Key points

  • 3 of the 12 held-out pairs also sit in the dev set.

  • OpenMed 3.1 won’t score split_overlap and the model is never loaded.

Sources

SWE-rebench V2.1 RL release – 13,337 free RL environments

SWE-rebench V2.1 RL is out with 13,337 free RL environments for coding agents in 20 languages using Harbor format. Fixed tasks, envs, and graders provide fast, reliable rollouts.

Key points

  • 13,337 free RL environments for coding agents (20 languages, Harbor format)

  • Fixed tasks, envs, and graders enable fast, reliable rollouts

Sources

Ez-PAVE statin-ezetimibe combo similar efficacy and safety

Ez-PAVE using a treat-to-target LDL-C strategy found that starting with statin-ezetimibe combination therapy or statin monotherapy gave similar cardiovascular efficacy and safety. The finding was presented at Scientific Sessions 26.

Key points

  • Combination therapy vs monotherapy gave similar cardiovascular efficacy.

  • Combination therapy vs monotherapy gave similar safety.

Sources

Immune cells - drive placental inflammation in preterm

Immune cells drive placental inflammation in preterm cases, while full-term cases have more healing and anti-inflammatory cells. Reported by @wustl and @sciencetm.

Key points

  • Finding: immune cells from both mother and baby drove aggressive placental inflammation in preterm cases

  • Finding: full-term cases had more cells that support healing and control inflammation

Sources

Function panel at Eudemonia Summit – 8 of 10 members act on results

Function’s Women’s Health Medical Director Tiffany Lester discussed turning results into action at the Eudēmonia Summit. 8 out of 10 Function members take action based on their results. The booth is #601 in the Expo.

Key points

  • 8 out of 10 Function members take action based on what they learn from their results.

  • Booth #601 in the Expo; find it by taking a right at the entrance and looking for plants.

Sources

WrightState tenfold reduction restores vessel function

WrightState reports a tenfold reduction in tiny cell-released particles restored normal blood vessel function in lab tests with severe early-onset preeclampsia samples. The result is not yet a treatment.

Key points

  • Tenfold reduction in tiny cell-released particles

  • Restored normal blood vessel function in lab tests using severe early-onset preeclampsia samples

Sources

From model to medicine: cardiovascular AI event

From model to medicine: the future of cardiovascular AI will be discussed at a Scientific Sessions event on Nov. 8. The session runs 8-9:15 AM CT in room N228 and includes AI investigators and journal leaders such as @CircAHA.

Key points

  • AI investigators & leaders of major journals, including @CircAHA, will discuss the modern evidence lifecycle of AI from development through deployment.

  • Nov. 8 | 8-9: 15 AM CT | N228, part of #ScientificSessions26.

Sources